Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
11.45
-0.25 (-2.14%)
Sep 25, 2026, 9:43 AM EDT - Market open
Immix Biopharma Employees
As of December 31, 2025, Immix Biopharma had 21 total employees, including 18 full-time and 3 part-time employees. The number of employees did not change compared to the previous year.
Employees
21
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,900,820
Market Cap
819.13M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | 0 | - | 21 | 0 |
| Dec 31, 2024 | 21 | 4 | 23.53% | 18 | 3 |
| Dec 31, 2023 | 17 | 6 | 54.55% | 14 | 3 |
| Dec 31, 2022 | 11 | 9 | 450.00% | 9 | 2 |
| Dec 31, 2021 | 2 | - | - | 2 | 0 |
| Sep 30, 2021 | 2 | - | - | 2 | 0 |
| Jun 30, 2021 | 2 | - | - | 2 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Ardelyx | 489 |
| 4D Molecular Therapeutics | 196 |
| Rigel Pharmaceuticals | 174 |
| Solid Biosciences | 121 |
| Theravance Biopharma | 90 |
| Inventiva | 77 |
| Candel Therapeutics | 55 |
| Avalo Therapeutics | 33 |
IMMX News
- 10 days ago - Immix Biopharma price target raised to $26 from $15 at Mizuho - TheFly
- 10 days ago - Immix Biopharma Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 24 days ago - Immix Biopharma Slides: Corporate presentation - Filings
- 6 weeks ago - Immix Biopharma price target lowered to $19 from $20 at Morgan Stanley - TheFly
- 6 weeks ago - Immix Biopharma Slides: Corporate presentation - Filings
- 6 weeks ago - Immix Biopharma price target raised to $25 from $20 at H.C. Wainwright - TheFly
- 7 weeks ago - Immix Biopharma Quarterly report: Q2 2026 - Filings
- 7 weeks ago - IMMX Investors Have Opportunity to Join Immix Biopharma, Inc. Fraud Investigation with SBS Law - Business Wire